XLerateHealth

XLerateHealth, founded in 2013 and based in Louisville, Kentucky, is an accelerator firm dedicated to supporting early-stage healthcare companies in developing their commercialization strategies. The firm focuses on two categories of pre-venture-funded portfolio companies: affiliates, which have made significant progress in establishing beta sites and strategic relationships, and startups, which require intensive mentorship and support. XLerateHealth assists these companies in navigating their connections with payers, providers, and customers, including employers and consumers. For affiliate companies, the accelerator offers mentorship and networking opportunities aimed at enhancing their commercialization efforts and facilitating institutional fundraising. Through its targeted support, XLerateHealth plays a vital role in fostering innovation within the healthcare and life sciences sectors.

Robert Saunders Ph.D

Chairman and Co-Founder

46 past transactions

Lealtà

Pre Seed Round in 2022
Lealtà is a SaaS company that develops a patient membership platform based on a neurobehavioral framework that drives patient loyalty and healthy choices for better care and financial outcomes.

Bainom

Pre Seed Round in 2022
Bainom is an AI and machine learning-based platform for genomic data analysis. The platform matches genetic data with up-to-date information from scientific databases and scientific articles to provide actionable insights for personalized health and wellness. Bainom guides solutions for individualized predisposition, prognosis, management, and therapy for health conditions.

Ensofy

Pre Seed Round in 2022
Ensofy develops an AI-enabled mental health monitoring tool for mental health disorders. Ensofy allows healthcare providers to easily monitor and manage the mental health of their patients. VoiceAI requires 30 seconds of free-form speech to assess depression with demonstrated diagnostic accuracy rates of up to 80%, supporting clinicians and caretakers in mental health management decisions.

Prevada Medical

Pre Seed Round in 2022
Prevada Medical is a MedTech company that offers solutions to address one of the most common medical errors occurring in our hospitals today, ventilator-associated pneumonia. Prevada develops a disposable mouthpiece for mechanically ventilated patients to significantly reduce the likelihood of deadly lung infections. Prevada Medical's easy-to-implement solution provides additional protection against VAP-related pathogens without impeding current workflows or requiring labor-intensive and risky reintubation procedures.

Coordinista

Pre Seed Round in 2022
Coordinista gives providers the tools needed for effective care delivery at any point of care from transitional to chronic care management, resulting in increased engagement, productivity, and improved health outcomes.

Amplified Sciences

Seed Round in 2021
Amplified Sciences LLC is a molecular diagnostics company based in West Lafayette, Indiana, focused on developing a point-of-care system for the early detection of debilitating diseases, including pancreatic cancer and kidney disease. Utilizing an ultra-sensitive molecular sensing technology licensed from Purdue University, Amplified Sciences offers a versatile platform that can detect low abundance disease markers from bodily fluids such as urine and saliva. This technology is designed to operate at the single molecule level, allowing for accurate diagnostics while maintaining a cost-effective structure. The company has successfully produced a working prototype and published proof of concept data, positioning itself to address significant unmet medical needs in disease detection. With a scalable product portfolio aimed at point-of-care applications, Amplified Sciences is poised to transform early disease diagnosis and improve healthcare outcomes.

Tremblock

Pre Seed Round in 2021
Tremblock designs and develops a mouthguard for use in patients with seizure disorders. Tremblock's device is capable of dispensing a quick-acting seizure aborting medication designed to protect teeth, tongue, lips, and other oral structures from injury.

Active Therapy Systems

Pre Seed Round in 2021
Active Therapy Systems is a company based in Nicholasville, Kentucky, founded in 2017. It specializes in developing an interactive exercise platform designed to provide in-home therapies for individuals living with Parkinson's disease. The platform aims to enhance the management of Parkinson's through personalized therapies and remote patient monitoring, allowing users to engage in activities that may help alleviate their symptoms. By focusing on the specific needs of those affected by Parkinson's, Active Therapy Systems seeks to improve their quality of life and promote greater independence in daily activities.

Heartbeat Technologies

Pre Seed Round in 2021
Heartbeat Technologies is a clinical innovator focused on improving outcomes for cardiac arrest patients through the development of a novel cardiopulmonary resuscitation adjunct device. This device enhances survival rates by preferentially redirecting blood perfusion to critical areas of the body, thereby minimizing neurological impairment during recovery. It is designed for use in both field and hospital settings, allowing healthcare institutions to effectively implement it in various emergency and clinical scenarios. Through its innovative approach, Heartbeat Technologies aims to merge healthcare and design to advance patient care and recovery in critical situations.

20Lighter

Pre Seed Round in 2021
Provider of a weight loss program intended to help users to achieve their weight loss and health goals. The company has two flagship programs which are a combination of smart technology, patent-pending meal plans, all-natural anti-inflammatory supplementation along with expert personal attention and regime, enabling users to lose weight and visceral fat and lead a healthy lifestyle.

Melanated Healthcare

Pre Seed Round in 2021
Melanated Healthcare is a digital health platform focused on improving healthcare access for black and brown patients. The platform aims to reduce health disparities by connecting users with culturally competent healthcare professionals who understand their unique needs. By facilitating these connections, Melanated Healthcare strives to ensure that melanated individuals receive equitable, non-discriminatory healthcare services tailored to their cultural contexts.

DRSLINQ

Pre Seed Round in 2021
DRSLINQ is developing a mobile EKG device that is coupled to an interactive application powered by a natural language processing integrated with a machine learning platform to appropriately triage chest pain patients to the ER.

Adlore

Pre Seed Round in 2021
is a device for the treatment of lower extremity wounds that are difficult to heal, such as diabetic or neuropathic foot ulcers, venous stasis leg wounds, and arterial and ischemic ulcers. Their device improves healing rates by supplying heat, thermo-regulated electrical pulse stimulation to increase blood flow, and a feedback sensor to monitor performance. Performance information will be communicated to the patient via a proprietary APP and via Wi-Fi to the clinician.

Gluconfidence

Seed Round in 2020
Glucoconfidence is a veteran-owned company dedicated to empowering individuals with diabetes to lead unrestricted lives. It develops innovative, low-calorie, all-natural liquid glucose supplements specifically designed for the insulin-dependent diabetic community. These products are formulated to be fast-acting and concentrated, with optimal osmolality for enhanced absorption into the bloodstream. By providing a convenient source of glucose, Glucoconfidence aims to promote health and well-being among diabetic patients. The supplements are available for easy online delivery and are developed by individuals with diabetes, ensuring they meet the needs and preferences of their target audience.

BooknDoc

Seed Round in 2020
BooknDoc is a software-as-a-service platform that facilitates real-time connections between patients and healthcare providers, including primary care physicians, specialists, and dentists. The platform enables users to secure same-day appointments through various options, including in-practice visits, telehealth consultations, and house calls. By allowing doctors to fill last-minute openings in their schedules, BooknDoc enhances the efficiency of medical practices. Furthermore, the platform helps companies optimize their employee benefits packages, leading to reduced healthcare costs and improved employee well-being. This, in turn, contributes to enhanced overall company performance by minimizing absenteeism related to health issues.

Dr. Opinion

Seed Round in 2020
Dr. Opinion is a web-based API designed to combat fraudulent dental insurance claims using artificial intelligence. We are trying to solve the dental insurance fraud using radiographic image analysis. Our solution will help insurance enterprises to reduce cost and make healthcare affordable for everyone. Our company has 100% focus on the dental fraud problem.

RxLightning

Seed Round in 2020
RxLightning is a developer of a specialty prescription management platform that aims to simplify the enrollment process for patients starting specialty medications. By digitizing and automating this traditionally complex manual procedure, the platform enhances efficiency across various therapeutic areas, including addiction medicine, cardiology, endocrinology, and dermatology. This innovative approach allows healthcare providers to minimize paperwork, improve communication, and expedite access to therapy for patients, ultimately contributing to better health outcomes.

Mediscan

Seed Round in 2020
Mediscan is a developer of a digital platform that enhances hospital operations by utilizing sensor-based AI and an Internet of Things (IoT) capable network. The company's technology transforms traditional hospital infrastructure into smart facilities, enabling improved visibility and efficiency in clinical administration. Mediscan focuses on optimizing patient flow and admissions processes while ensuring cyber-physical security. A key feature of their offering is an automated operational assistant named "ALICE," which autonomously collects and interprets critical data, allowing hospital executives to make informed decisions in real-time. By simplifying data collection and analysis, Mediscan helps hospital staff prioritize patient care over administrative tasks.

Repatient

Seed Round in 2020
Repatient is a digital platform that offers interest and fee-free payment plans to assist patients in managing their increasing out-of-pocket medical expenses. By allowing payments to be spread over time, the platform facilitates access to both essential and elective healthcare services. This approach not only ensures that patients receive necessary medical care but also enhances cash flow for hospitals and clinics. Additionally, Repatient's model eliminates the need for credit checks or denials, thereby fostering stronger relationships between healthcare providers and their patients while reducing the burden of collections on providers.

IBIS Therapeutics

Seed Round in 2020
IBIS Therapeutics tackles the problem of therapeutic efficacy using a unique AI engine capable of predicting absorption, distribution, metabolism, excretion, and toxicity to identify the best drug candidates from a quarter billion small molecules.

2innovate

Pre Seed Round in 2020
2innovate specializes in creating visionary medical devices that dramatically improve quality of care by reducing morbidity and mortality while significantly reducing healthcare costs.

HealthOpX

Seed Round in 2020
HealthOpX L.L.C. is a company that has developed an online platform aimed at assisting patients and community health workers in managing social determinants of health. Founded in 2018 and based in East Lansing, Michigan, HealthOpX provides various services, including health appointment assistance, checklists, caregiver guidance, and access to community resources. The platform focuses on improving the health of at-risk patients through predictive analytics, facilitating care coordination, enhancing medical adherence, and boosting patient engagement. By offering these tools, HealthOpX enables healthcare practitioners to deliver quality care outcomes more conveniently and cost-effectively, ultimately benefiting patients, hospitals, and caregivers alike.

Bell Tech Communications

Pre Seed Round in 2020
Bell Tech Communications improves communication between hearing and deaf communities by translating native Speech and Text language Input into real-time conversations, including Visual Sign Language and Text Output messaging, through assistive technology tools.

Crosby Innovations

Pre Seed Round in 2020
Crosby Innovations is a medical equipment manufacturing company. They provide develop devices to utilize UVC technology for skin sanitization applications.

SafetySit

Pre Seed Round in 2020
SafetySit is a company focused on creating assistive therapeutic devices aimed at supporting disabled or recovering patients who struggle to maintain an upright sitting position due to insufficient core muscle strength. The company has developed a mobile backrest designed to aid clinicians in treating these patients, facilitating the early mobilization process essential for recovery. This innovative product reduces the need for clinicians to provide manual support, thereby enhancing the efficiency of therapy sessions and improving overall patient outcomes. By prioritizing user comfort and clinical effectiveness, SafetySit aims to advance rehabilitation practices and support the recovery journey for individuals with mobility challenges.

DSC Technologies

Pre Seed Round in 2019
DSC Technologies focuses on developing a point-of-care blood plasma assay aimed at differentiating between Type I and Type II heart attacks. The company's innovative approach employs Differential Scanning Calorimetry (DSC), a thermoanalytical technique that measures the heating profiles of blood plasma samples in comparison to reference materials. This method allows healthcare professionals to analyze plasma samples effectively, assisting in the accurate identification of myocardial infarction. By providing a reliable tool for diagnosing heart attacks, DSC Technologies seeks to enhance patient care and improve clinical outcomes.

Briocare

Pre Seed Round in 2019
Developer of an artificial intelligence-driven senior care platform created to improve the quality of life for seniors. The company's platform uses voice technology to eliminate caregiver anxiety and offers complete control and access to scheduled care events, and daily reports on the senior's activities and well-being, while also providing health tips and content, enabling seniors to increase social interactions in daily life.

AssayMe

Pre Seed Round in 2019
AssayMe is a personal wellness and health assistant that empowers patients to monitor their health conditions and prevent potential medical issues through a simple, at-home urine test. The company combines proprietary urine test strips with advanced technology in its app, allowing users to assess 14 key health parameters in just two minutes. In addition to the testing, the app collects users' medical histories through a survey and offers the option to consult a doctor if needed. This comprehensive approach provides a convenient, accurate, and cost-effective solution for individuals seeking to manage their health more effectively.

Clinitraq

Pre Seed Round in 2019
Real Time Location Based Radiation Dosimetry IoT technology

Hardin Scientific

Seed Round in 2019
Hardin Scientific is a manufacturer of laboratory equipment focused on enhancing productivity and efficiency in the life sciences sector. The company provides high-quality tools and materials designed to facilitate scientific discovery while ensuring compliance with ISO and FDA regulations. By prioritizing ease of use and simple maintenance, Hardin Scientific aims to reduce equipment turnover and minimize operational expenses for laboratories. Their innovative approach leverages advanced materials, components, and software to create a powerful laboratory platform that aligns with the goals of scientists, ultimately streamlining workflows and decreasing redundancy in research. Through these efforts, Hardin Scientific seeks to address the technological challenges faced by the life science community and promote a new era of precision biotechnology.

HealthFreelance.com

Pre Seed Round in 2019
Operator of a healthcare professional hiring platform intended to transform the healthcare industry with skilled people. The company's platform offers to hire creative and valuable professionals by matching profiles with vacant positions and has a diverse collection of healthcare businesses and freelancers that believe in a nimble, independent method to connect and get work done, enabling clients to immediately fill positions in a time-saving way.

Bisep

Pre Seed Round in 2019
BISEP is a medical device innovation company with a goal to enhance performance in physical rehabilitation and therapy. We produce high-quality ambulation training devices that are helpful in improving sedentary lifestyle and independence for seniors, the physically, and neurologically impaired. Our first device is the A.R.M.M. (Ambulation, Mobility, Retraining and Mobility Mechanism). Founded in 2016, Daniel Bordenave, an experienced kinesiologist, noticed the biggest pain point in the healthcare system and his passion to serve his profession intrigued him to devise the solution to this problem. The limited funding sources and equipment were the main hindrance to rehabilitation and ambulation training. BISEP has worked hard to provide a safer rehab tool for therapists, patients and caregivers.

Opira

Pre Seed Round in 2019
Opira has a three-dimensional imaging modality that uses the photoacoustic effect. Optical coherence tomography is an optical imaging modality that produces high-resolution volumetric images of microstructures in materials and biological samples in real-time using low-coherence light. OCT images are tissue cross-section morphology maps.

DesiCorp

Pre Seed Round in 2018
DesiCorp is focused on developing innovative freeze-dried red blood cell technology aimed at extending the shelf-life of blood products. This technology results in a thermally stable powder that can be used by medical practitioners in various challenging environments, including battlefield settings, disaster relief operations, and remote rural areas where refrigeration is unavailable. By enabling on-site transfusions and allowing for indefinite stockpiling of blood, DesiCorp aims to enhance emergency medical care and ensure that essential blood supplies are accessible in critical situations.

EnMed MicroAnalytics

Pre Seed Round in 2018
EnMed MicroAnalytics developed a screening solution to detect heavy metals in newborns and pregnant women. The proprietary EEvCard is a screening solution used to detect lead and other heavy metals that cause physical and mental damage in babies. The solution tests the blood sample to detect the blood-metal levels in newborn babies, young children, and pregnant women.

Airis Health

Pre Seed Round in 2018
Developer of digital healthcare platform designed to provide artificially intelligent physician workflow solutions. The company's platform is a mobile messaging application that acts as a virtual assistant for physicians for on-call schedules and one-click to call, message, or page anyone, enabling clients to have hospital workflows yielding lower overall costs and higher reimbursements.

Astarte Medical

Seed Round in 2018
Astarte Medical Partners, Inc. develops a software that provides a universal view of clinical data in real time to assess the state of the preterm infant’s gut health to make more informed decisions. The product enables NICU clinical care teams to standardize and streamline the practice of feeding. Astarte Medical Partners, Inc. was incorporated in 2016 and is based in Yardley, Pennsylvania.

Fetal Life

Seed Round in 2018
Fetal Life is a healthcare company focused on enhancing the pregnancy experience through innovative solutions that support both expectant mothers and postpartum care. The company develops medical devices to monitor contractions and fetal heartbeats, combined with a mobile app that facilitates self-management of health, weight monitoring, and gestational diabetes. By integrating telehealth services and data analysis, Fetal Life aims to provide comprehensive care throughout the pregnancy journey. Their products are designed to be affordable, portable, and user-friendly, allowing pregnant women to better navigate their challenges with accessible medical expertise and technology.

EBlu Solutions

Pre Seed Round in 2016
EBlu Solutions LLC, founded in 2013 and based in Louisville, Kentucky, specializes in designing and implementing product support programs for manufacturers in the pharmaceutical, medical device, and equipment sectors. The company focuses on managing the complexities of high-cost infusion and injection treatments, offering services that include benefits investigations, prior authorizations, and co-pay card management. By streamlining the workflow associated with these therapies, EBlu Solutions aims to reduce the risk of denied claims, enhance staff efficiency, and simplify training and onboarding processes for medical practices. The company operates as a joint venture between KiZan Technologies, LLC and Bluegrass Healthcare Management Group, LLC.

Orthopedix

Pre Seed Round in 2016
Orthopedix develops 3D-printed orthopedic implants. The implants are individually sized and shaped to fit each patient's unique anatomy, enabling patients to have perfect orthopedic implantation for their bodies.

Epikardis Medical

Pre Seed Round in 2016
Epikardis Medical LLC is a medical company focused on identifying ineffective methods and products in the medical field and developing cost-efficient replacements with clear, proven benefits.

Blue Sky Case Management

Pre Seed Round in 2014
Blue Sky Case Management is a dedicated agency that specializes in providing case management services for adults and children diagnosed with intellectual and developmental disabilities (IDD) who receive support through the Kentucky Department of Medicaid Services. The agency is composed of a team of experienced social service professionals who prioritize high-quality care for Medicaid members and their families. By leveraging mobile web-based technology, Blue Sky simplifies case management practices and streamlines daily operations, resulting in improved quality of care outcomes while minimizing administrative costs. The agency is committed to fostering collaboration between case managers and clients, empowering them to work together for the best possible experiences for Medicaid members.

Count.It

Pre Seed Round in 2014
Count.It is a New York City-based start-up that provides a fitness-focused platform designed to enhance employee wellness through physical activity challenges. The platform integrates with wearable devices, such as Fitbits, and messaging tools like Slack, allowing co-workers to engage in collective fitness activities. By converting users' activity data into a daily score, Count.It encourages participation in community fitness challenges and promotes healthier lifestyles in the workplace. The service aims to streamline the management of employee wellness programs, reducing both costs and administrative burdens for companies while motivating employees to be more active.

Apellis Pharmaceuticals

Funding Round in 2013
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, dedicated to developing therapeutic compounds that inhibit the complement system to address autoimmune and inflammatory diseases. The company's lead candidate, pegcetacoplan, is undergoing Phase III clinical trials for geographic atrophy associated with age-related macular degeneration and paroxysmal nocturnal hemoglobinuria, while also being assessed in Phase II trials for several other conditions, including cold agglutinin disease and lupus nephritis. Additionally, Apellis is developing APL-9, which is currently in Phase I clinical trials aimed at preventing immune activation related to adeno-associated virus. The company collaborates with Swedish Orphan Biovitrum AB to advance pegcetacoplan for various rare diseases. Founded in 2009, Apellis focuses on creating innovative therapies for conditions characterized by excessive activation of the complement cascade across multiple medical fields, including hematology and ophthalmology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.